Lu Wei-Ting, Zalmas Lykourgos-Panagiotis, Bailey Chris, Black James R M, Martinez-Ruiz Carlos, Pich Oriol, Gimeno-Valiente Francisco, Usaite Ieva, Magness Alastair, Thol Kerstin, Webber Thomas A, Jiang Ming, Saunders Rebecca E, Liu Yun-Hsin, Biswas Dhruva, Ige Esther O, Aerne Birgit, Grönroos Eva, Venkatesan Subramanian, Stavrou Georgia, Karasaki Takahiro, Al Bakir Maise, Renshaw Matthew, Xu Hang, Schneider-Luftman Deborah, Sharma Natasha, Tovini Laura, Jamal-Hanjani Mariam, McClelland Sarah E, Litchfield Kevin, Birkbak Nicolai J, Howell Michael, Tapon Nicolas, Fugger Kasper, McGranahan Nicholas, Bartek Jiri, Kanu Nnennaya, Swanton Charles
The Francis Crick Institute, London, UK.
CRUK Lung Cancer Centre of Excellence, London, UK.
Nat Cell Biol. 2025 Jan;27(1):154-168. doi: 10.1038/s41556-024-01558-w. Epub 2024 Dec 30.
Chromosomal instability (CIN) is common in solid tumours and fuels evolutionary adaptation and poor prognosis by increasing intratumour heterogeneity. Systematic characterization of driver events in the TRACERx non-small-cell lung cancer (NSCLC) cohort identified that genetic alterations in six genes, including FAT1, result in homologous recombination (HR) repair deficiencies and CIN. Using orthogonal genetic and experimental approaches, we demonstrate that FAT1 alterations are positively selected before genome doubling and associated with HR deficiency. FAT1 ablation causes persistent replication stress, an elevated mitotic failure rate, nuclear deformation and elevated structural CIN, including chromosome translocations and radial chromosomes. FAT1 loss contributes to whole-genome doubling (a form of numerical CIN) through the dysregulation of YAP1. Co-depletion of YAP1 partially rescues numerical CIN caused by FAT1 loss but does not relieve HR deficiencies, nor structural CIN. Importantly, overexpression of constitutively active YAP1 is sufficient to induce numerical CIN. Taken together, we show that FAT1 loss in NSCLC attenuates HR and exacerbates CIN through two distinct downstream mechanisms, leading to increased tumour heterogeneity.
染色体不稳定性(CIN)在实体瘤中很常见,通过增加肿瘤内异质性促进肿瘤进化适应并导致预后不良。对TRACERx非小细胞肺癌(NSCLC)队列中的驱动事件进行系统表征发现,包括FAT1在内的六个基因的基因改变会导致同源重组(HR)修复缺陷和CIN。使用正交遗传学和实验方法,我们证明FAT1改变在基因组加倍之前被正向选择,并与HR缺陷相关。FAT1缺失会导致持续的复制应激、有丝分裂失败率升高、核变形以及结构CIN升高,包括染色体易位和放射状染色体。FAT1缺失通过YAP1失调导致全基因组加倍(一种数值CIN形式)。YAP1的共同缺失部分挽救了由FAT1缺失引起的数值CIN,但不能缓解HR缺陷和结构CIN。重要的是,组成型活性YAP1的过表达足以诱导数值CIN。综上所述,我们表明NSCLC中FAT1缺失通过两种不同的下游机制减弱HR并加剧CIN,导致肿瘤异质性增加。